ATA17442001A - Strukturelle und funktionelle charakterisierung von cdw92 - Google Patents

Strukturelle und funktionelle charakterisierung von cdw92

Info

Publication number
ATA17442001A
ATA17442001A AT17442001A AT17442001A ATA17442001A AT A17442001 A ATA17442001 A AT A17442001A AT 17442001 A AT17442001 A AT 17442001A AT 17442001 A AT17442001 A AT 17442001A AT A17442001 A ATA17442001 A AT A17442001A
Authority
AT
Austria
Prior art keywords
cdw92
structural
functional characterization
characterization
functional
Prior art date
Application number
AT17442001A
Other languages
English (en)
Other versions
AT413701B (de
Original Assignee
Bmt Medizinische Forschung Und
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bmt Medizinische Forschung Und filed Critical Bmt Medizinische Forschung Und
Priority to AT17442001A priority Critical patent/AT413701B/de
Priority to PCT/AT2002/000312 priority patent/WO2003040286A2/de
Priority to AU2002342381A priority patent/AU2002342381A1/en
Publication of ATA17442001A publication Critical patent/ATA17442001A/de
Application granted granted Critical
Publication of AT413701B publication Critical patent/AT413701B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT17442001A 2001-11-06 2001-11-06 Strukturelle und funktionelle charakterisierung von cdw92 AT413701B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT17442001A AT413701B (de) 2001-11-06 2001-11-06 Strukturelle und funktionelle charakterisierung von cdw92
PCT/AT2002/000312 WO2003040286A2 (de) 2001-11-06 2002-11-06 Immunmodulation durch das cdw92 molekül
AU2002342381A AU2002342381A1 (en) 2001-11-06 2002-11-06 Cdw92 molecule induced immunomodulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT17442001A AT413701B (de) 2001-11-06 2001-11-06 Strukturelle und funktionelle charakterisierung von cdw92

Publications (2)

Publication Number Publication Date
ATA17442001A true ATA17442001A (de) 2005-09-15
AT413701B AT413701B (de) 2006-05-15

Family

ID=3688797

Family Applications (1)

Application Number Title Priority Date Filing Date
AT17442001A AT413701B (de) 2001-11-06 2001-11-06 Strukturelle und funktionelle charakterisierung von cdw92

Country Status (3)

Country Link
AT (1) AT413701B (de)
AU (1) AU2002342381A1 (de)
WO (1) WO2003040286A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0203164A2 (hu) * 1999-05-25 2002-12-28 Aventis Pharma S.A. Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékei
FR2800750B1 (fr) * 1999-11-05 2003-01-31 Centre Nat Rech Scient Proteines membranaires ctl (choline transporter like) impliquees dans le transport de la choline
EP1240322A2 (de) * 1999-12-23 2002-09-18 Exiqon A/S Therapeutische anwendungen von lna-modifizierten oligonukleotiden

Also Published As

Publication number Publication date
WO2003040286A2 (de) 2003-05-15
AT413701B (de) 2006-05-15
AU2002342381A1 (en) 2003-05-19
WO2003040286A3 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
DE60227301D1 (de) Strukturen von anschlusselementen und anzuschliessende komponente
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE60229061D1 (de) Herstellung und verwendung von nanopartikel
DE60206344D1 (de) Baueinheit von Leuchten und Zubehör
DE60238206D1 (de) Frequenz- und amplitudenapodisierung von wandlern
ATE401339T1 (de) Mischungen von cyclosporin-analogen und ihre verwendung als immunmodulatoren
DE50202479D1 (de) Saure pigmentdispergatoren und pigmentzubereitungen
DE60218695D1 (de) Biosensoren und messverfahren
EP1424365A4 (de) Pastöse zusammensetzung und diese enthaltende kosmetika
DE60210904D1 (de) Nitrit-stabilisierte Zusammensetzungen von Tetrazolium-Reagenz und Methoden derer Nutzung
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
DE60238576D1 (de) Zusammensetzung zur Herstellung von Elektroden und Elektroden
EP1418940A4 (de) Dna expressionsvektoren und verwendungsverfahren
NO20041272L (no) Tetracycline derivatives and methods of use thereof
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
ATE319308T1 (de) Kombinationen von cyclohexandionoxim-herbiziden und safeners
DE50212455D1 (de) Verwendung von Dimerdiolen
BRPI0208558A2 (pt) preparado de combinação de estrogênio-gestagênio e uso
EP1499186A4 (de) Verwendung von häm-oxygenase-1 und häm-abbauprodukte
EP1476159A4 (de) Zusammensetzungen und formulierungen von 9- nitrocamptothecin-polymorphen und verwendungsverfahren dafür
PT1390516E (pt) Novos vectores de expressão e uso dos mesmos
DE60121951D1 (de) Charakterisierung nichtlinearen Verhaltens
DE60230438D1 (de) Racemat von tamsulosin als freie base und dessen herstellungsverfahren
EP1578917A4 (de) Multimere proteine und verfahren zu deren herstellung und verwendung

Legal Events

Date Code Title Description
MM01 Lapse because of not paying annual fees

Effective date: 20110915